USPTO serial 79455194
Reviewed by CopyMark Law Group
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Drug discovery services; providing information on the testing, inspection and research of medical products; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; development of pharmaceutical preparations and medicines; consultancy in the field of testing, inspection, research of medical products; scientific research conducted using databases; development of computer software for big data processing; research and development services in the field of chemistry; provision of scientific information relating to chemicals; chemical analysis; research and development of vaccines and medicines; research and development of pharmaceutical preparations for treating malignant tumours; computer programming in the medical field; research and development services in the field of microorganisms and cells; biotechnology research; scientific research; computer software development; drug discovery services by computer modeling; research and development of computer software platforms in the field of artificial intelligence; software as a service [SaaS] relating to artificial intelligence based deep learning software for visual and data analysis in the medical and biotechnological field; software as a service [SaaS] relating to software for data collection, data analysis, data storing and data mining in the field of healthcare and biotechnology; software development for artificial intelligence service; providing PaaS (platform as a service) in the field of pharmaceuticals; computer software development for promoting research in science, medicine, pharmaceutical, biology, biotechnology, biological informatics, clinical development and statistics fields; computer software development for data analysis in medical and biotechnology fields using algorithms for deep learning; computer software development in the field of new drug discovery and new drug development. | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 29, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 28, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 27, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 10, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 10, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 30, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |